Research Funding

Melanoma Research Alliance and Prostate Cancer Foundation Seek Applications for Team Science Partnership Award

The Melanoma Research Alliance and the Prostate Cancer Foundation are inviting applications for one jointly sponsored team science award that will simultaneously advance clinical science in both diseases.

A total award amount of up to $1.5 million over two to three years is offered to support innovative, meritorious, and translational work with the potential for high clinical impact in prostate cancer and melanoma.

Examples of investigative areas relevant to both kinds of cancer for which applications will be considered include 1) nuclear imaging technologies and/or applications as early predictors of treatment outcomes, including novel tracers to distinguish immune from tumor cells in the context of immunotherapy; 2) therapeutic interventions targeting tumor cell metabolism and protein translation; and 3) development of effective combinatorial therapies in the adjuvant or advanced disease setting based on immune-modulating drugs paired with other agents.

Link to Complete RFP

Leave a Reply

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.